Paeds SAQs · preventive-and-community-paediatrics
Newborn bloodspot screening for inherited metabolic disease and follow-up — formative SAQs
Two formative SAQs on critical bloodspot positives in well neonates, incomplete cards, galactosaemia feed safety and MCADD crisis pathways.
On this page
Study tools
Target exams
RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
Newborn bloodspot screening for inherited metabolic disease and follow-up
SAQ 1 — Critical TSH in a well neonate (20 marks, ~15 minutes)
A 6-day-old term infant is at home and feeding well. The bloodspot laboratory reports a critical elevated TSH. Parents are anxious and ask whether review can wait until next week because “he looks perfect.” [3]
Questions
- Define screening versus diagnosis in this setting and state the result-state urgency. (4 marks) [14]
- Outline your same-day management steps, including confirmatory testing and treatment principles for congenital hypothyroidism. (6 marks) [3]
- Explain the pathophysiology that makes well appearance an unsafe reassurance. (5 marks) [3]
- Write the safety-net and handover content you would document. (5 marks) [17]
Model answer (must-hit)
- Screen positive/presumptive positive is not a final diagnosis; it requires confirmatory free T4/TSH and a defined pathway. Critical markers need same-day contact, not routine delay. [3] [14]
- Phone family; arrange urgent clinical review and confirmatory thyroid function tests; start levothyroxine on the current protocolised pathway with endocrine follow-up; do not wait for developmental signs. State you use local dosing protocol rather than inventing figures. [3]
- After birth, maternal/placental thyroid support falls. Low thyroxine injures the developing brain while growth and feeding may still look acceptable. [3]
- Document result state, tests done, treatment started or timed, who owns follow-up, contact numbers, and advice for poor feeding, lethargy or jaundice concerns. [17]
References5ShowHide
- [3]van Trotsenburg P, Stoupa A, Léger J, et al. Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update. Thyroid, 2021.PMID 33272083
- [7]Mason E, Hindmarch CCT, Dunham-Snary KJ Medium-chain Acyl-COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment. Endocrinology, diabetes & metabolism, 2023.PMID 36300606
- [10]Berry GT Galactosemia: when is it a newborn screening emergency? Molecular genetics and metabolism, 2012.PMID 22483615
- [14]Dietzen DJ, Rinaldo P, Whitley RJ, et al. Follow-up testing for metabolic disease identified by expanded newborn screening. Clinical chemistry, 2009.PMID 19574465
- [17]O'Leary P, Maxwell S Newborn bloodspot screening policy framework for Australia. Australasian medical journal, 2015.PMID 26464586